Allele-specific expression in the human heart and its application to postoperative atrial fibrillation and myocardial ischemia

Table 2 SNPs with allele-specific expression in the LV

SNP	Gene	Chr	Location	Samples	Reads	REF/ALT + REF	FDR adj. p value
rs76148815	MTR	1	237,063,719	92	8029	0.07	5 × 10^–217
rs7772210	MTCH1	6	36,936,771	58	8199	0.91	1 × 10^–209
rs2260914	ZSCAN18	19	58,598,784	50	2967	0.07	2 × 10^–199
rs1046138	PKP2	12	32,944,162	64	21,767	0.92	8 × 10^–194
rs2075846	OXA1L	14	23,239,512	66	14,818	0.92	5 × 10^–178
rs200574632	MUL1	1	20,826,784	64	3728	0.94	3 × 10^–127
rs17850531	ECHDC3	10	11,805,339	56	2467	0.97	5 × 10^–109
rs164577	SLC30A5	5	68,417,755	84	1374	0.03	8 × 10^–107
rs312185	AP2S1	19	47,342,867	76	2040	0.96	2 × 10^–114
rs2586306	ABR	17	909,451	76	2626	0.06	4 × 10^–114

The table shows the ten SNPs with the most significant ASE in the LV samples (n = 3774), the gene they are located within, the genomic location, number of heterozygous samples and reads overlapping the SNP available for ASE calling, the REF/ALT + REF ratio, and the FDR-adjusted p value for ASE

ISSN: 1756-994X